Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways.
A recent trend in drug development is to identify drug combinations or multi-target agents that effectively modify multiple nodes of disease-associated networks. Such polypharmacological effects may reduce the risk of emerging drug resistance by means of attacking the disease networks through synerg...
Guardado en:
Autores principales: | Jing Tang, Leena Karhinen, Tao Xu, Agnieszka Szwajda, Bhagwan Yadav, Krister Wennerberg, Tero Aittokallio |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/464fb0e478384c6487cf3e21f71300fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
por: Alba Di Pardo, et al.
Publicado: (2017) -
MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer
por: En-Chi Hsu, et al.
Publicado: (2021) -
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas
por: Aswini Krishnan, et al.
Publicado: (2020) -
Melanoma Targeted Therapies beyond <i>BRAF</i>-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches
por: Karam Khaddour, et al.
Publicado: (2021) -
Inhibiting the Mammalian Target of Rapamycin Blocks the Development of Experimental Cerebral Malaria
por: Emile B. Gordon, et al.
Publicado: (2015)